← Scroll for more →
Artiva Biotherapeutics, Inc. (ARTV)
Biological Products, (No Diagnostic Substances)
Latest Price
$4.19
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
14.06
P/B Ratio
0.30
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 17.96M | $174.0M | 55.96% | +8.10M | 2026-06-30 |
| Viking Global Investors LP | 2.60M | $25.0M | 8.12% | -- | 2026-06-30 |
| Blackstone Inc. | 2.40M | $23.0M | 7.49% | -- | 2026-06-30 |
| 5AM Venture Management, LLC | 2.35M | $22.0M | 7.33% | -- | 2026-06-30 |
| Venrock Adviser, LLC | 2.04M | $19.0M | 6.37% | +434.0K | 2026-06-30 |
| Franklin Resources Inc | 2.00M | $19.0M | 6.22% | +1.48M | 2026-06-30 |
| Caligan Partners LP | 1.74M | $16.0M | 5.41% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 981.8K | $9.0M | 3.06% | +774.1K | 2026-06-30 |
| Samsara Biocapital, LLC | 954.9K | $9.0M | 2.98% | +663.2K | 2026-06-30 |
| Blue Owl Capital Holdings LP | 874.5K | $8.0M | 2.73% | -- | 2026-06-30 |